Send Inquiry

Request To Call Back

Coronary Stent - Sirolium

Name: Coronary Stent - Sirolium
Brand: Advin Health Care
Price: 200 USD
Availability: InStock

Price 200 USD ($)/ Piece

Get a Price/Quote

MOQ : 1 Piece

Coronary Stent - Sirolium Specification

Usage Type
Single Use

Function
Revascularization of coronary arteries

Accuracy
High placement precision

Features
Biocompatible, Flexible, Non-corrosive

Measurement Range
Diameter 2.5 mm to 4.0 mm, Length 8 mm to 38 mm

Instruments Type
Interventional Cardiology

Storage Instructions
Store in a cool & dry place, avoid direct sunlight, keep in original packaging

Shelf Life
3-5 Years

Equipment Type
Coronary Stent

Material
Cobalt Chromium Alloy

Condition
New

Technology
Drug Eluting Stent (DES)

Portable
Yes

Wall Mounted
No

Real-Time Operation
Yes

Noise Level
Silent

Operating Type
Manual deployment

Use
Coronary Artery Disease treatment

Dimension (L*W*H)
Vary by size (typical length: 8-38 mm, diameter: 2.5-4.0 mm)

Weight
Lightweight

Color
Metallic Silver

Thrombogenicity
Low

Release Profile
Sustained drug release up to 60 days

Endothelialization
Rapid, due to sirolimus coating

Drug Coating
Sirolimus

Compatibility
5F, 6F, and 7F guiding catheters

Sterilization
ETO (Ethylene Oxide) sterilized

Strut Thickness
~70-80 microns

Radiopacity
Enhanced for easy visualization

Expansion Method
Balloon expandable

Delivery System
Over-the-wire (OTW)

Possible Balloon Diameter
2.5 - 4.0 mm

About Coronary Stent - Sirolium

Advin Health Care offers Coronary Stents Sirolimus Eluting designed to meet international quality standards. These drug-eluting stents (DES) are coated with sirolimus, an antiproliferative agent that helps reduce restenosis by inhibiting smooth muscle cell proliferation, ensuring long-term vessel patency and improved clinical outcomes in coronary artery disease treatment.

Key Features

Sirolimus drug coating for reduced restenosis rates
Controlled drug release for sustained therapeutic effect
Thin strut design for enhanced flexibility and deliverability
High radial strength for optimal vessel support
Biocompatible polymer coating for safety and performance

Specifications

Type: Drug Eluting Coronary Stent (Sirolimus)
Material: Cobalt Chromium / Stainless Steel
Drug: Sirolimus
Coating: Biocompatible polymer-based drug coating
Delivery System: Balloon-expandable system
Sterilization: EO Sterilized
Usage: Single-use
Application: Treatment of coronary artery disease (CAD) via PCI procedures

Certifications
CE, ISO 13485, and ISO 9001 certified

Product Keywords
Sirolimus Eluting Stent, Drug Eluting Coronary Stent, DES Stent, Coronary Stent, Angioplasty Stent, Cardiac Stent

DES

, , , , ,

Stent liberador de sirolimus, stent coronario liberador de frmacos, stent DES, stent coronario, stent de angioplastia, stent cardaco

Stent lution de sirolimus, stent coronaire lution de mdicament, stent DES, stent coronaire, stent d'angioplastie, stent cardiaque

Optimal Drug Release Technology

Featuring sustained sirolimus release for up to 60 days, this stent inhibits excessive tissue growth, reducing the probability of restenosis. The advanced drug-coating technology ensures controlled drug delivery and accelerates the healing process within coronary arteries, supporting better patient outcomes and rapid vascular recovery.

Precision and Compatibility

Engineered for high placement accuracy, the stent offers compatibility with multiple guiding catheter sizes-5F, 6F, and 7F-allowing interventional cardiologists flexibility in diverse procedural settings. Its refined strut thickness and superior radiopacity facilitate precise positioning and clear visualization throughout deployment.

Reliable and Safe Performance

Manufactured from cobalt chromium alloy and sterilized with ETO, the stent is both non-corrosive and biocompatible. Its low-thrombogenicity profile, lightweight construction, and balloon-expandable deployment provide consistent safety and efficacy, making it suitable for various clinical scenarios.

FAQ's of Coronary Stent - Sirolium:

Q: How does the sirolimus coating benefit patients receiving this coronary stent?

A: The sirolimus coating delivers a sustained release of medication for up to 60 days, which suppresses excessive tissue regrowth and lowers the risk of restenosis, while also promoting rapid endothelial healing for improved patient recovery.

Q: What is the deployment process for the Sirolium coronary stent?

A: The stent is manually deployed using a balloon-expandable over-the-wire (OTW) system. Compatible with 5F, 6F, and 7F guiding catheters, it is positioned within the coronary artery and expanded using an angioplasty balloon for precise placement.

Q: When should this drug-eluting stent be used in coronary artery disease treatment?

A: This stent is suitable for revascularization in patients with narrowed or blocked coronary arteries, especially when long-term prevention of vessel re-narrowing and rapid healing are desired outcomes.

Q: Where should the coronary stent be stored prior to use?

A: It should be stored in a cool, dry place, within its original packaging, and away from direct sunlight to maintain sterility and product integrity until use.

Q: What is the benefit of the stent's enhanced radiopacity?

A: The enhanced radiopacity allows for easy and accurate visualization under fluoroscopy during procedures, ensuring precise placement and optimal clinical outcomes.

Q: How does the stent ensure safety during use?

A: Made from biocompatible, non-corrosive cobalt chromium alloy and sterilized using ETO, the stent has a low potential for thrombogenicity, thus minimizing the risk of complications during and after implantation.

Tell us about your requirement